+987.9%
MRNA vs ROIV
+97.8%
+890.1%
-34.2%
Performance
Returns, benchmark comparison, and relative performance.
Performance by timeframe
Returns for 1y.
| Period | Portfolio | ROIV | Excess | Alpha |
|---|---|---|---|---|
| 1D | +13.1% | +6.1% | +7.0% | +10.4% |
| 7D | +20.6% | +3.0% | +17.6% | +19.2% |
| 30D | +27.1% | +6.8% | +20.3% | +23.6% |
| 3M | +353.4% | +10.5% | +342.9% | +324.9% |
| 6M | +446.3% | +34.8% | +411.5% | +360.7% |
| YTD | +776.2% | +76.2% | +700.0% | +594.7% |
| 1Y | +987.9% | +92.4% | +895.5% | +698.7% |
| All | +987.9% | +97.8% | +890.1% | +698.7% |
Cumulative growth
Daily Returns
Daily percentage return beside ROIV.
Daily Out/Under-Performance
Portfolio return minus ROIV return. Positive bars indicate outperformance.
Daily Alpha
Portfolio daily return minus β × ROIV return. Early observations use the first valid beta; later observations use the trailing beta estimated for each date.
Cumulative Out/Under-Performance
Relative wealth over 1y: compounded portfolio wealth divided by compounded ROIV wealth, less one. Both series rebase at the selected span's start.
Cumulative Alpha
Compounded beta-adjusted residual returns apply the first valid beta to early observations, then the trailing beta ending on each date.
Updating return analytics…
1y analysis · Full analysis span regression · 6 months rolling